Rongtao Medical Prepares for EU MDR Compliance Ahead of November Deadline

Guangzhou-based independent medical device supplier Rongtao Medical has released findings regarding the evidence requirements for ultrasound replacement parts under the European Union’s Medical Device Regulation (MDR). As the November 28 deadline for EUDAMED integration approaches, the company is emphasizing the necessity for technical documentation to accompany individual parts.

The firm’s analysis indicates that current U.S. regulatory clearance databases do not adequately cover individual ultrasound spare boards, highlighting a potential oversight in supply chain documentation. Rongtao Medical argues that distributors and repair providers must ensure that technical evidence follows the part directly to satisfy EU regulatory scrutiny.

This move aligns with broader industry efforts to standardize the aftermarket for diagnostic imaging components. As regulatory bodies continue to tighten oversight on medical device maintenance, the ability of third-party providers to demonstrate traceability will be critical for operations within the European market.